UN Geneva Press Briefing: ILO, WHO, WFP, IFRC

Okay.
Let's start.
Good morning.
Welcome to the press briefing.
Today is Tuesday 4th of August.
We are here in Geneva, the United Nations and I'd like to start immediately by giving the floor to our colleagues of the World Health Organization Tariq.
I think you would like to have some introductory remarks before we give the floor to doctor Vai Morty, who is the acting lead of WHOR&D Blueprint.
You are both in Geneva to tell us about treatment and vaccines for the Ebola disease.
So I'll give you the floor first and then we'll go to the doctor.
Thank you.
Thank you very much, Alice, good morning to everyone.
Before we go to the specific topic of treatment and vaccines for Wound Buga virus, just to remind you that you have received on Saturday the latest disease outbreak news and you have lots of details there.
But really the key message is that the outbreak is unfortunately still expanding beyond the capacity of the response and it is now the largest outbreak of Ebola the country has ever faced.
We need more support in terms of finances, but also other resources to scale up all areas of response, treatment capacity, field investigation teams, safe burial teams, and community workers.
And we need really to focus the response to where the virus is and where it might go next.
I will just give you the latest numbers.
As of August 1st, 3,748 confirmed cases including 1,657 confirmed deaths, and then the case had been reported from 49 health zones across five provinces that are around 17,000 contacts and monitoring, and 80% of them are checked daily.
So these are really the figures that you, sorry.
Can you release, please, the figures, I'm looking at people's faces.
Can you just repeat all these key numbers, please? Sure.
Sure.
And I will send this in my notes, so there is no problems with that, but I will just repeat that as of August 1st, 3,748 confirmed cases within 1,657 confirmed bets.
And I will again send these numbers immediately after we finish this briefing.
But today, we have doctor Vasi Marty, who is acting lead for WHO Research and Development blueprint to talk about another aspect of this outbreak, and that is a search for treatments and vaccines.
So I'll give the floor to doctor Vasi immediately.
He has to leave at 11.
So let's hear from him immediately.
Thank you.
Doctor Val, thank you so much, Terri.
Thank you.
Can you hear me okay? In the room.
Very well.
And we can see you.
Go ahead.
Thank you.
So I'd just like to start by saying that it's really important that we're clear that the R&D response that I'm going to summarize, I'm going to go through the progress, and there is promising progress with clinical trials of treatment of prophylaxis and of vaccines.
But we do know that it's not a case of waiting for these medicines and vaccines to come along.
There's a lot that can be done now by continuing to strengthen the response.
Teq highlighted the critical elements of both.
We know that early access to care and supportive care can save lives.
So in the way that these trials are being set up, they are integrated into the response, and we're supporting patient referral pathways.
We're supporting strengthening of the clinical management facilities and the surveillance and the contact tracing.
But it is true that there are no proven safe and efficacious treatment or prophylaxis or vaccine options.
The WHO R&D blueprint exists as a global R&D preparedness program.
With partners, this has led to the development of platform protocols for evaluation of treatment, prophylaxis and vaccine options as soon as they are available for clinical trials.
So this has been work that's been ongoing for many years preceding the outbreak exactly for this scenario where we need to accelerate clinical trials as much as possible.
And we are seeing that this has greatly accelerated the timelines to starting ethical, high quality clinical trials.
So just to go through the trial, firstly, the treatment trial.
So this is known as the Partners trial.
That's an acronym.
The protocol is publicly available, and we can share the link.
That is now open in three different sites, three different clinical management facilities, working with A lima and MSF in the Ituri province.
And that is now enrolled.
Over 50 cases have been randomized to the treatment options that are part of this trial.
As more sites gradually open for enrollment, we do expect that the speed of enrolling additional cases will continue to increase.
And the trial is enrolling confirmed cases of bicleo disease in these treatment facilities.
Moving on to the second trial, Prophylaxis Study, which is not a WHO study, the treatment Partners trial is sponsored by WHO.
Prophylaxis trial by contrast is not a WHO study.
It's led by the National Institute of Biomedical Research, INRB in the Democratic Republic of the Congo, together with an International Consortium of Research and Outbreak Response Partners, and ANRS, the emerging infectious disease part of the French National Medical Research Agency also has a critical role in the Prophylaxis trial.
And so this is a trial of a potential post exposure prophylaxis medicine, oral oval desvia the first time there has been a trial of an oral prophylaxis patient in an outbreak.
That's also underway in Aturirovin, and that has enrolled over 25 high risk contacts to evaluate whether this oral medicine given for ten days can prevent onset of disease in high risk contacts.
Moving on to the vaccine, which is also progressing very quickly, the first bdibgo specific candidate vaccine developed by Oxford University and Serum Institute of India started a phase one trial in the UK on the 24th of July, just over a week ago.
And the second vaccine specific to Bunjbo developed by Moderna is due to start anytime we understand imminently this week, a phase one trial in Canada.
And just to close with stating that any efficient scientific review system as we have a WHO will always look at new data that is emerging as the evidence base changes.
And we are seeing new data emerging on whether or not VB, which is the licensed Ebola vaccine that has been used previously in Ebola, what was formerly called Zaïre outbreaks.
There is new data that is coming out in animals as to whether or not this provides cross protection against Bundibugio virus in these animal models.
So because there's a fair amount of data that's emerging, we reconvened our R&D blueprint vaccine Technical Advisory Group last Friday to review this data, and we're finalizing the statement from that meeting that will be published later this week.
Thank you.
I'll stop there and happy to take questions.
Thank you very much, Doctor.
That was really interesting.
Let me open now the floor to questions in the room first, Christian, the German news agency DPA.
Thank you, Alessandra.
My question is, could you tell us for each of those trials, if they run as expected in a positive way, how long would it take for this to be widely available to people in the Congo? Thank you.
Thank you.
Yes.
I cannot give you an exact date because it depends on a lot of factors that are not clear at the moment.
So for all of these, we are trying to ramp up the enrollment.
So it depends on how many sites within the affected area are open for enrollment.
Because they're clinical trials, we have to have safe monitoring of the people that are enrolled in the trial, and that does take time to have more and more teams and more sites enrolling patients.
That's the number one factor that we don't know yet.
Number second factor, clearly we don't know is how effective these patients are if they prove to be effective.
I mean, that's not known yet.
So I would say it's still going to be several months, but we are going to, with all of the partners, do everything we can to accelerate timelines clearly.
And we have a process where we are trying to make sure that we can draw conclusion as soon as possible.
So the sort of most conservative way of doing this would be to have a fixed number of people that we wait until we enroll.
But in this case, what we're doing is we have a a more agile system where we have an independent group that which is called the data monitoring committee that has access to the results that the rest of us don't have access to.
And there is a pre stated schedule where they will look at the result.
And if it is clear that there is compelling benefit, then they will tell us we need to stop the trial.
So that could happen as soon as there is proven benefit, but it is not going to be for some months from now.
I'm sorry.
It doesn't Robin AFP.
Thank you.
Just on this vaccine that might provide cross protection in animals, could that be something that is potentially very positive news? Then secondly, on these phase one trials that are taking place in the UK and Canada, can you give a bit more detail as to how that's actually working in these pre clinical trials, what they're actually doing? Thank you.
Yes.
So on Avibo, I think it's best if I point you to the report that is going to come out in a few days, which goes through our evaluation of Avibo there has been a lot of discussion about ongoing studies, some of which are not published.
So I'm afraid I have to be a bit careful about what I can say.
We're getting permission from the people who are conducting these studies to share some of the results, and that is going to be shared in the report that will come out in a couple of days this week, we hope.
On the vaccine.
So The process there is that both pre clinical studies are needed.
So in this case, ferret studies is a well established model whereby ferrets are vaccinated and they're given bund poplio virus in a very safe controlled setting.
So this is happening for both of these vaccines, the Oxford Padox vaccine, which is the same platform as the estrogea COVID vaccine.
But with the Bunbia protein in it.
So that the ferret studies are underway, and we hope to receive them as soon as they're available in the weeks ahead.
The same for the moderna product.
It's also within ferret studies.
Then a non human primate studies, some monkey studies which are more similar to humans.
Those are also underway for both.
But in parallel Phase one study is starting.
So in the Phase one study, relatively small numbers of people, healthy consenting volunteers in Oxford and in Canada are given different doses of the vaccine so that they can look at the immune response as well as the safety.
And by comparing the immune response to different doses, that's how they will select which dose will be potentially taken into the phase three study.
So the process here will be once we have data after a few weeks of administration in the Phase one study that highlights the safety and the immune response.
Together with the animal studies, the ferret studies and the monkey studies, the W Tank will be convened again to look at the data from the Oxford Serum Institute vaccine and the Moderna vaccine, and then we'll decide whether that data is supported for them to be added to the phase three trial.
Yeah.
Go ahead, Christian.
Yes.
I think at the start of your introductory remarks, did you say that the RND response there is promising progress? Did I get that right? What I was saying is that if you compare this outbreak to previous Ebola outbreaks, we have been able to start trials more quickly.
So the reason for that is a promising progress in the way we're doing the R&D because the protocols were written before the outbreak started.
So this is the whole way that the whole world of research related to outbreaks has been trying to shift that we do as much as possible ahead of time.
But also, it's true that the preclinical data that we're seeing is promising.
So but you never know if that is going to translate into demonstrating that the medicines or the vaccines are promising until you get the results from the clinical trial.
Thank you very much.
Robin, you have a follow up? It's been reported from the field in Ituri that there's been difficulty getting people to go into hospitals for treatment once they fall ill.
Have you encountered any difficulty in getting people to enroll for the trial? Would you have liked to have had more people enrolled than you've managed to have? Thank you.
Thank you.
We haven't had difficulties at the sites that are open.
So the limitation of the enrollment speed is the number of sites that are open for the treatment trial.
So so far we have three sites open.
I understand four is going to open later this week and we're really hoping that we can gradually get up to ten and then more sites that were open to.
So we do believe that as the clinical trial continues to expand in this somewhat cautious way just to make sure that it's all done to the highest ethical standards and with the highest quality science, that it could help with what you're talking about, to the extent to which people are really comfortable to present because as people gradually see that there is more and more access to treatment options, it does seem quite possible that there will be more interest in presenting for treatment.
Thank you very much.
Is there any other question for WHO? I don't see any in the room or on the platform, but I see that Tariq is saying that the notes have been sent, so you should have everything in your email.
Thank you very much.
Thanks, Tarik for bringing in the doctor and thanks, Doctor for this update this important date on the treatment and vaccines for Ebola.
I like now to go to another region, which is Asia and particularly Afghanistan.
From Kabul, we have John Aliyev, the WFP Country Director to tell us about the growing child nutrition crisis in the country.
John, welcome and please go ahead with your introductory remarks.
Thank you.
Thank you so much.
Thank you for this opportunity to talk about Afghanistan's nutrition crisis.
It's a crisis which is getting worse by the day and tragically one which we are unable to contain.
Child wasting, the deadliest form of malnutrition has reached critical levels in one third of the country's provinces now.
The number of children being rushed to health centers is soaring and we're seeing this visibly.
80% of the worst cases are children under two years of age.
NGOs report that too many of them are arriving too late to be saved.
August now, in other words, it's usually the summer month when child malnutrition peaks.
This year, the peak came weeks earlier than normal.
But this is not really a story about seasonality.
This is actually a story of how conflict, trade disruptions, and forced returns from neighboring countries are driving unprecedented levels of acute malnutrition in Afghanistan.
It's a story of how dramatic aid cuts mean that millions of acutely malnourished Afghan children are being turned away without assistance at the very moment when their lives are at risk.
It's a story of how too many children are dying in Afghanistan of acute malnutrition today, deaths which, of course, are fully preventable.
In Kandahar province a few days ago, we met Farida, a mother of three.
Farida is typical of Afghanistan's poorest citizens.
Her husband, an elderly street vendor, earns less than $1 a day, leaving the family with no chance of affording nutritious food, healthcare, or basic necessities.
Two of Farida's children suffer from anemia and her 6-year-old son has been too weak to attend school for months, too weak, too ill, and too acutely malnourished.
When we spoke to Farida, her baby started crying from hunger.
She reached into her bag and pulled out a child's bottle.
Now, normally, you expect the child's bottle to be full of milk.
This one only had weak tea in it.
There was simply no money in the household for milk.
Farida described the heartbreak of telling her hungry children again and again, night in, night out that there is nothing more to eat.
The family is barely surviving on tea and bread.
Farida told us categorically that if they were not receiving WFP food at the clinic, her children would undoubtedly die.
That's a hard message to hear, frankly, but harder still when you realize that WFP is only funded this year to feed one in seven acutely manurish women and children.
Yes, we are turning away six out of seven and we're turning them away empty handed with absolutely nothing.
The nutrition crisis today is a symptom of growing food insecurity in the country.
In the past three years, close to 6 million Afghans have been forcibly expelled from neighboring countries.
There are simply not enough jobs to sustain them.
Conflict with Pakistan and the Middle East crisis have created trade disruptions, which have pushed up the price of staple foods by 20 to 30%.
The poor are being priced out of the market.
At present, close to 14 million Afghans are acutely hungry in the past few months, crippled by funding cuts, WFP has been able to feed only one in nine of them.
As I address you today, WFP has stopped completely the food distributions which aim to prevent famine in very narrow targeted hotspots across the country.
We simply don't have the funding to continue.
I think it's tragic that too few are speaking up about the dire situation in Afghanistan and this nutrition crisis, which we feel is spinning out of control.
Calls for the international community to demonstrate humanity, solidarity, and shared values are not working sufficiently.
I therefore stress a further, a real concern that abject hunger drives migration, radicalization and ultimately brings in stability, and that instability, as history has shown, has a tendency to spill over beyond Afghans borders.
Is the reason that we need to be longsightd.
We need to act for the present to stem the current crisis, but also avoid the return of an unstable Afghanistan, something which clearly is in no one's interest.
Thank you.
Thank you very much, John, for this really appalling data and description of the situation in Afghanistan.
Let me open the floor to question now.
Robin is from our AFP office.
Good morning.
How much money do you need in dollar terms? How much are you asking for this year and how much do you actually have? Thank you.
Thanks, Robin.
Our program covering the malnutrition crisis and the general feeding is valued at about $900 million this year.
We have not met needs in the first six months because we didn't have money.
And when you look at the next six month window, this critical window, not just because of the current crisis, but also in the run up to winter, which is the flash the real flashpoint of hunger, WFP still needs $500 million to address acute food needs in the country.
Thank you very much.
Other questions? Let me look at the platform.
Do you have a follow up? Thank you.
In the best of all possible scenarios, to what extent would Afghanistan be able to feed itself with the increased population that it now has thanks to returns? Well, the increased population has been a dramatic problem since September 2023.
Roughly 6 million people have come back to the country forcibly expelled from neighboring countries.
This has created immense strain on the economy.
This makes the situation worse.
But there is not only doom and gloom, there is a better harvest this year, and it's coming in now.
What we're finding though, is the relief which would normally have been bought by this better harvest is being offset by the headwinds that I've described.
One of those headwinds, which I'll focus on is the dramatic cuts in aid funding.
Thank you.
So let me go to the platform Gorky from Lisre de desc and appraisals Joe Biden, Bank Central, Afghan.
So I design In particular, victim on September arrest Afghanistan, ground problems, Savoy prison America Biden, Opo Afghan, A Vi Americans Trump f the flesh abiden.
But it's a look the profiter who did Trump, San Andrés Mo predecessor and the pero assistant G Mercy.
Thank you so much for the question.
And if you figured me I would be more comfortable to respond in English, but I understood the question well.
I can't comment on the status of those reserves, the $7 billion because I don't have the information.
What I can tell you is that in spite of that, the economy is growing, but not growing at a pace which is fast enough to create the jobs needed to sustain the poorest families in Afghanistan and particularly families like Fida's family, the case I cited.
And that's why the underlying situation is so difficult here for them, exacerbated now by the factors we've talked about, the returns, the droughts and the flash floods and the earthquakes which we've had, and of course, the aid cuts, which don't help.
We would like all donors to be returning to Afghanistan to address the humanitarian situation, including the United States and others that have ceased funding Afghanistan.
Thank you very much.
Ara Ryan, the independent.
Hello.
Hi.
Can you hear me? Yes.
Go ahead.
Yeah.
I wanted to know what role have the de facto authorities played in aiding WSP in meeting the crisis? Are there any state led programs that can share your burden? That's one.
And would you say that this is the situation which is at its dire most since August 2021? Thank you for the questions.
Is this the worst situation we've seen since 2021? Yes, it is.
Even last year in 2025, we had already seen the highest surge in malnutrition ever recorded year on year and now 2026, we're seeing that situation even worse.
The health programs that I'm talking about, the ones that address malnutrition are implemented in the health clinics of the National Health Service.
They are the national health clinics, largely speaking, and so we're working side by side with the de facto authorities to deliver this aid.
We're delivering it independently, but through the health structures.
And I would just give a call out to the many extremely dedicated doctors and nurses that I've met in health clinics across the country in the last few months who are exhausted working around the clock.
And trying to fight a nutrition crisis with too few resources, too few resources from the World Foo Program, too few resources across the board.
It is heartbreaking to see them tell mothers who have walked for hours with their emaciated child in their arms, it's heartbreaking for them to tell those mothers that there's just nothing because aid cuts have prevented us from providing the food that would help their children regain their weight and regain their life.
Thank you very much.
Robin again.
Thank you.
Just to check that I've understood this correctly, is your total ask for 2026 900 million and you've received 400 million so far, is that correct? I apologize.
I realized my answer to the question was not clear when I was talking.
We needed 900 million at the beginning of the year.
We've received 130 million so far.
But when WP has failed to feed people in the first six months of the year, we don't keep asking for that money.
We reduce the needs accordingly.
And so you can safely say that feeding one out of nine people in Afghanistan who needed food, one out of nine acutely hungry people has been an opportunity which we missed, which we can't come back to.
So we stop asking for the money over the last six months that we failed to gain.
Again, just to state in the coming six months from July to the end of the year, we still need $500 million and that will help us to bring the nutrition crisis under control and to really feed people who without international assistance, really have nothing to survive on.
Sorry.
Thank you very much.
And I'm counting on Gemma for sending your notes to the journalist.
I'm sure she will do it if it's not already done.
John, thank you so much.
Really very dire situation.
We wish you all the best for your important work.
Keep us updated on what goes on and especially on the funding side.
Yeah, thank you very much again.
So let me now go to IFRC.
Dirk Seger, who is the IFRC special envoy for Sudan just returned from Sudan and he's here to tell us about his mission and the needs there.
Hi, Dirk.
Please go ahead.
Hi, Alessandra.
Hello, colleagues.
Good morning.
Thank you for the opportunity to brief you this morning.
Last week, I traveled by road from Port Sudan to A Baga and then onto Shiny, Oman, and Htun, meeting communities affected by the conflict and the Sudanese First Crescent volunteers supporting them every day.
One message became very clear throughout this long journey.
While the world's attention focuses, rightly so on Darfur and Kordofan, the conflict affected areas, the consequences of more than three years of conflict are being felt across the entire country.
Sudan is one of the largest humanitarian crisis, yet it's also one of the most overlooked.
Today, 35 million people need humanitarian assistance.
That's about two thirds of the entire population.
More than 9 million are internally displaced and 4.5 million have fled the country.
The Sudanese Red Crescent is uniquely positioned to respond, supported by the International Federation of Red Cross and Red Crescent Societies, IFC, with 122,000, active volunteers across all 18 states.
It has the access, it has the trust, and it has community acceptance needed to reach people where others often cannot.
But these volunteers cannot meet overwhelming needs without greater international support.
In Al Nada camp near Al Paga, I met families who had escaped fighting in Darfur and Kordofan, especially from Al Fasha after days crossing the desert.
Many arrived exhausted, malnourished, and injured.
I also realized these are the lucky ones who managed to get away.
The camp, however, sits in a barren landscape with no shade whatsoever and temperatures exceeding 40 degrees Celsius every day.
Despite having very limited resources, the Sudanese Wet Crescent volunteers are running mobile health services.
They are providing water and sanitation, supporting women and children, and helping people rebuild a sense of dignity.
When I traveled further south along the Nile and Shiny, a small agricultural town, I found a situation where nearly 400,000 displaced people have found refuge in this small community.
The Sudanese Wet Crescent manages shelters, distribute essential relief items and cash assistance, and supports vulnerable families through a social safety net program.
Then, when I reached Khartoum, the destruction was impossible to ignore.
Large part of the center remained devastated.
Yet, during the fighting, while many organizations had to leave, the Sudanese crescent state, its volunteers continued providing first aid, transporting the wounded and ensuring the dignified burial of the dead under extremely dangerous conditions.
And I spoke to them extensively.
I thanked them also from the bottom of my heart.
It was so impressed with what they did.
And they said we wanted to bring hope and compassion when violence and hatred was all around us.
24 volunteers have lost their lives while serving their communities during this conflict.
They are true humanitarian heroes.
Today, Khartoum is entering a new phase, but the challenges remain immense.
Millions of people continue to live with limited access to electricity, clean water, and healthcare.
According to ION, nearly 4 million people have voluntarily returned to Sudan, concentrated, particularly in Khartoum and Al-Jazirah while another 200,000 displaced people have recently arrived from Darfur and Kordofan.
You can imagine with so many people who have stayed in the city deeply affected after more than three years of conflict, then having to deal with all these people returning to their homes often damaged a large number of people, which is positive, but also very challenging, and then so many people displaced directly from the most conflict affected areas.
It is an incredible challenge.
At the same time, cholera has reemerged, malnutrition remains widespread and the rainy season increases the risk of flooding and disease outbreaks.
When I was there, there were eight confirmed cases of cholera in Khartoum.
The Sudanese red crescent is responding through mobile clinics, cash assistance, cholera prevention, community health campaigns, and flood preparedness.
But the witness was not only a conflict.
Throughout the journey, I saw a country trying to survive after more than 1,200 days of conflict.
This crisis is no longer only about fleeing people fleeing violence.
It's about families who have spent years away from home, communities that have continued sharing their limited resources with displaced neighbors, and people returning to cities where homes, schools, and hospitals have been damaged.
And despite everything, I also witnessed resilience.
In Khartoum, as the evening falls, families gather outside, children play and cafes reopen.
People are beginning to reclaim their city and rebuild their lives, despite all the challenges they still face.
That hope deserves our support.
Today, only 35% of the IFAC emergency appeal for Sudan is funded.
And at a time when needs continue to grow, human resources are shrinking.
World really cannot afford to look away.
The Sudanese re President has the volunteers, the trust, and the determination to save lives.
And what it urgently needs is the support to continue doing so.
Thank you very much.
Thank you very much, Dirk.
And before I open the floor to question, I just wanted to inform you that the personal envoy of the Secretary-General Pkvisto is continuing to engage with the various parties, and he's traveling to Turkey this week, where he will meet with Turkish authorities as well as with Sudanese stakeholders in the country in the country there in Turkey, including youth and women's representatives.
And I'd also like to add that the Under Secretary-General for Humanitarian Affairs, Tom Fletcher, stressed that humanitarians are scaling up efforts, and we've heard it to reach the family seat by the conflict, escially North Kordofan, and we will seize every opportunity to expand lifesaving aid in and around Ebaid.
He called on the parties to de escalate, protect civilian, and ensure humanitarian access.
And on the financial side, we urge donors to increase their support for the humanitarian response.
For the UN, this year's appeal for Sudan is just over 40% funded with about 1.2 billion received against the nearly $2.9 billion required.
And I open the floor to questions.
If any in the room or on the platform, I don't see any hand up on this important matter, but thank you very much, Dirk, for this briefing for telling us what you've seen and what you're doing there.
And thanks and good luck with your important work.
Let me go to our last speaker.
I'd like to ask on to come to the podium to give us an announcement for ILO Hello, you can hear me now? Yes, just a small announcement from the International Labor Organization, as we announced yesterday and probably most of you received in your mailbox.
The International Labor Organization is going to be releasing next week the Global Employment Trends for Youth 2026.
The Global Employment Trends for Youth is the ILO's flagship Global report on the labor market situation of young people aged.
15 to 2024.
It provides the latest global and regional data on youth, employment, unemployment, labor force participation, and need.
These are young people who are not in employment education or training.
It also analyzes main economic and social factors that are shaping Youth labor markets.
As we announced yesterday, the embargoed copies will be available in all related press materials to credit media upon request.
Also, for those of you interested, we will be holding next week as well, a online briefing with the authors of the report and also the Director of the ILO's employment Skills and Sustainable Enterprises.
The embargoed will be lifted on Tuesday next week, 11th of August at 2,300.
The online media briefing will be also on Tuesday, but it will be 14-1500.
Upon invitation, we are welcome to send you the online Zoom link.
With that, you can write to newsroom at o.org if you have not received the email if you're interested in the embargoed reports, and we're happy to provide all the related press material.
Thank you.
Thank you, Yvonne.
Let me see if there are any questions to you.
I don't see ends up, thank you very much.
You have almost finished.
And if there is any question for ILO you have the address.
This is basically what we had for you today.
I just wanted to add a small two announcements.
One on the conference on disarmament that, as you know, has started the last part of its 2026 session on the 27th of July.
The session will last until the 11th of September and on next Thursday, 6th of August at 10:00 A.M.
The conference will hold a plenary meeting on the following topic, cesssion of the nuclear arms race and nuclear disarmament.
This is under the presidency of Norway.
Norway will be president until the 14th of August, and then Pakistan will follow from the 17th of August to the 11th of September.
That is about what I wanted to tell you.
If there are yes, no, just another thing.
This is just housekeeping, but starting from tomorrow, you will find us all in building C and S.
We are moving today and tomorrow.
If we don't answer your questions today quickly, you know why.
But you will find the whole of units between the six door and door four starting from tomorrow and will be operational hopefully there.
So that's a small announcement for you if you look for us.
So thank you very much.
I'll wish you a good afternoon, and we'll see you on Friday.
Thank you.